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ORIGINAL ARTICLE
Bilateral ECT induces bilateral increases in regional
cortical thickness
P van Eijndhoven1,2, P Mulders1,2, L Kwekkeboom1, I van Oostrom1, M van Beek1, J Janzing1, A Schene1,2 and I Tendolkar1,2,3
Electroconvulsive therapy (ECT) is the most effective treatment for patients suffering from severe or treatment-resistant major
depressive disorder (MDD). Unfortunately its underlying neurobiological mechanisms are still unclear. One line of evidence
indicates that the seizures produced by ECT induce or stimulate neuroplasticity effects. Although these seizures also affect the
cortex, the effect of ECT on cortical thickness is not investigated until now. We acquired structural magnetic resonance imaging
data in 19 treatment-resistant MDD patients before and after a bilateral ECT course, and 16 healthy controls at 2 time points, and
compared changes in cortical thickness between the groups. Our results reveal that ECT induces signiﬁcant, bilateral increases in
cortical thickness, including the temporal pole, inferior and middle temporal cortex and the insula. The pattern of increased cortical
thickness was predominant in regions that are associated with seizure onset in ECT. Post hoc analyses showed that the increase in
thickness of the insular cortex was larger in responders than in non-responders, which may point to a speciﬁc relationship of this
region with treatment effects of ECT.
Translational Psychiatry (2016) 6, e874; doi:10.1038/tp.2016.139; published online 23 August 2016
INTRODUCTION
Although electroconvulsive therapy (ECT) is the most effective
treatment for patients suffering from severe or treatment-resistant
major depressive disorder (MDD),1 achieving faster and higher
response rates than pharmacotherapy,2 the underlying neuro-
biological mechanisms remain poorly understood. Several
hypotheses, based on the effects of ECT on monoamine systems
and endocrine function, have been proposed.3 In explanations of
its superior effectiveness, the neuroplasticity effects of ECT have
become dominant.
The therapeutic efﬁcacy of ECT is related to its capacity to
generate a generalized epileptic seizure.4 Animal models of
electroconvulsive stimulation have shown that convulsions
cause neuroplasticity effects.5 ECT-induced seizures engage both
cortical and subcortical networks to varying degrees and result
in increased cerebral blood blow in focal cortical areas.6,7 In
line with these broad hemodynamic effects of ECT on the brain,
recent research indicates that next to effects on volume of
hippocampus8–10 or amygdala11,12 ECT induces also neuroplasti-
city effects in the cortex.9,13 Up till now, there are no studies that
have used cortical thickness analysis to investigate the effects of
ECT treatment, which is a sensitive method to study longitudinal
changes in the cortex.14
Cortical thickness represents the thickness of the outer layer of
gray matter in the brain which varies greatly between species and
also between cortical subregions within subjects.14 Differences in
cortical thickness have been observed in a variety of neuropsy-
chiatric disorders.15,16 Emerging evidence indicates that cortical
thickness is affected in MDD, primarily expressed as regional
thinning in the cingulate and orbitofrontal cortex17–21 although
areas of thickening have also been found.21,22 A recent, large
meta-analysis of cortical thickness in 20 depression cohorts
worldwide gathered in the ENIGMA group, conﬁrmed thinning
of the orbitofrontal cortex and cingulate cortex, and also identiﬁed
thinning of the insula and temporal lobes.23 In contrast with
decreases in hippocampal volume, which was mainly associated
with recurrent depression,24 cortical thickness changes were
robustly detectable in adult patients at their ﬁrst episode.23
Based on the fact that ECT-induced seizures affect the cortex,
we hypothesize that ECT leads to regional increases in cortical
thickness. A secondary goal is to identify changes in cortical
thickness that may be related to treatment response.
MATERIALS AND METHODS
Subjects
Twenty three patients (8 male/15 female; age 50.7 ± 8.5 years) with
treatment-resistant MDD were recruited at the department of psychiatry of
the Radboud University Medical Centre Nijmegen. Sample size was based
on previous studies investigating the longitudinal effects of ECT on
structural measures such as hippocampal10 and gray matter9,13 volume. All
patients were diagnosed with MDD using the Structural Interview for DSM
disorders (SCID) and were eligible to receive ECT treatment based on
treatment resistance for medication, according to the Dutch guidelines for
depression and ECT.25 Brieﬂy this means that patients had failed to
respond to a stepwise treatment including serotonin- or serotonin–
noradrenaline-reuptake inhibitors, tricyclic antidepressants and augmenta-
tion with lithium or anti-epileptics, and in some cases MAO-inhibitors
before receiving ECT. Exclusion criteria were bipolar depression, having
received ECT within 1 year prior to the current course, schizophrenia or a
history of alcohol or substance abuse. Twenty two sex- and age-matched
healthy controls (8 male/14 female; mean age= 50.8 ± 8.8 years) were
recruited from the local area by advertisement. Exclusion criterion for
controls was having any life-time psychiatric disorder. Exclusion criteria for
all persons included were present or past relevant somatic or neurologic
1Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands; 2Donders Institute for Brain Cognition and Behavior, Centre for Cognitive
Neuroimaging, Nijmegen, The Netherlands and 3Faculty of Medicine and LVR Clinic for Psychiatry and Psychotherapy, University of Duisburg-Essen, Essen, Germany.
Correspondence: Dr P van Eijndhoven, Department of Psychiatry, Radboud University Medical Center, Postbus 9101, Nijmegen 6500 HB, Netherlands.
E-mail: philip.vaneijndhoven@radboudumc.nl
Received 17 January 2016; revised 29 May 2016; accepted 9 June 2016
Citation: Transl Psychiatry (2016) 6, e874; doi:10.1038/tp.2016.139
www.nature.com/tp
comorbid disorder, and magnetic resonance imaging (MRI)-related
exclusion criteria such as claustrophobia, a pacemaker or pregnancy.
Patients were tapered off from all psychotropic medication, such as
antidepressants, antipsychotics, mood stabilizers and benzodiazepines at
1 week before the start of ECT. Only incidental use of benzodiazepines or
promethazine was permitted during the course of ECT.
During the course of ECT treatment, severity of depression was
measured using the Hamilton Depression Rating Scale (HDRS-17).26 All
participants provided written informed consent and the study protocol
was approved by the review board of the Radboud University Nijmegen
Medical Centre.
ECT-series
ECT was administered bilaterally at the temporal window using a brief
pulse, constant current apparatus with a maximum stimulus output of
1008 mC (200%) (Thymatron System IV, Somatics, Lake Bluff, IL, USA).
Seizure threshold was determined during the ﬁrst session with stimulus
titration. The seizure threshold is deﬁned as the minimum stimulus dosage
required to generate a generalized seizure of at least 20-s duration
according to the cuff method. For the second treatment session, a stimulus
intensity of 1.5 times the initial seizure threshold was used. Global anesthesia
was achieved by administering i.v. etomidate (0.2–0.3 mg kg− 1), followed
by succinylcholine 1.0 mg kg− 1 to achieve muscle relaxation. Patients
received treatment twice a week for as long as there was substantial
improvement in symptom severity. When no improvement was measured
after at least 10 adequate treatment sessions or no further improvement
during the last 4 sessions, treatment was discontinued. On average,
patients were treated 18 ± 7 times (range 7–32 sessions).
Procedure
Patients were assessed at two time points: T1, 1 week before the ﬁrst ECT
treatment; and T2, within 1 week of completing the ECT series. Of the 23
patients examined at T1, 19 patients completed T2. Drop out was caused
by defect scanner (two patients) and to patient-initiated discontinuation of
ECT (two patients). Of the 22 healthy controls that were examined at T1, 16
were re-examined at T2, with a time interval similar to the mean of the ECT
series, to control for timing and test–retest effects. The longitudinal effects
of ECT were analyzed by comparing changes in cortical thickness between
the patients and controls with data for both T1 and T2.
Imaging technique and cortical thickness measurements
High-resolution MPRAGE images were acquired (1.5 T Avanto, Siemens,
Erlangen, Germany) for all subjects. Acquisition parameters were: T1 850
(ms), TR 2250 (ms), TE 3.68 (ms), ﬂip angle 15 (°), FoV 256× 256× 176 (mm),
voxel-size 1.0 × 1.0 × 1.0 (mm).
The MRI data were analyzed by using FreeSurfer software version 5.3.0
(http://surfer.nmr.mgh.harvard.edu). This software package is almost
completely automated and reliably computes cortical thickness. The data
were motion corrected and intensity normalized. We performed segmen-
tation of white matter and tessellation of the gray–white matter junction.
Topological defects in the gray–white estimate were ﬁxed. Then a
deformable surface algorithm was applied to ﬁnd the pial surface. We
visually inspected the entire cortex in each subject and corrected any
inaccuracies in segmentation manually. The reconstructed cortical surfaces
were inﬂated to normalize interindividual differences in gyral or sulcal
depth. Each reconstructed brain was morphed and registered to an
average spherical surface representation so that sulci and gyri were
optimally aligned and cortical thickness difference maps could be
constructed on a common spherical coordinate system.
To extract reliable thickness estimates, images of subjects were
automatically processed within the longitudinal stream in FreeSurfer.27
Speciﬁcally an unbiased within-subject template space and image was
created using robust, inverse consistent registration.28 Several processing
steps, such as skull stripping, Talairach transforms, atlas registration, as well
as spherical surface maps and parcellations were then initialized with
common information from the within-subject template, signiﬁcantly
increasing reliability and statistical power.27
Statistical analysis
After smoothing (full width at half maximum, 10 mm21), the cortical
thickness data were averaged across subjects in the spherical coordinate
system, so that surface areas with signiﬁcant differences of mean cortical
thickness could be overlaid in statistical difference maps (using t-statistics).
We addressed cross-sectional differences between the MDD patients and the
healthy controls at baseline, corrected for age and sex. Longitudinal changes
between the two time points for the two groups were analyzed with the
general linear model functionality within QDEC, FreeSurfer’s graphical
interface for analyzing group data. We estimated for the whole brain
(in vertex-wise statistical difference maps) the main effect of group (ECT
versus healthy controls), on symmetrized percent change of the cortical
thickness corrected for age and sex. Correction for multiple comparisons was
applied by clusterwise correction, based on Monte Carlo Z simulation, build
into QDEC (threshold 0.005, sign absolute).29
In a second step, we compared responders (n= 10) and non-responders
(n=9) to ECT by a whole-brain analysis. In addition to this exploratory
whole-brain analysis looking into effects of successful treatment, we also
performed a post hoc analysis with independently deﬁned cortical
parcellations (from the Desikan–Killiany Atlas), to explore whether there
were effects associated with response (deﬁned as a decrease in HDRS of
450%), within the regions that showed the longitudinal increases in the
ﬁrst step (that is, insula, temporal pole and temporal cortex). Changes in
mean thickness of these parcellations were analyzed with SPSS (Statistic
Package for the Social Sciences) software version 20.0 (Armonk, NY, USA),
with independent t-tests. Further, these absolute changes in thickness
were used for exploratory correlational analyses (Pearson's correlations,
Po0.05 one-tailed) with clinical variables: age, change in Hamilton
depression score and parameters linked to the ECT course: that is, number
of ECT sessions, change in charge between last and ﬁrst session and
change in seizure duration between ﬁrst and last session.
RESULTS
Patient characteristics are summarized in Table 1. There were no
signiﬁcant differences between MDD patients and healthy
controls in age, sex distribution, level of education or handedness.
Hamilton scores after (12.6 ± 7.1) on average 16.9 ± 6.2 ECT
sessions differed signiﬁcantly from Hamilton scores (21.9 ± 5.3)
before ECT (Po0.001). HDRS based response rate was 57%. There
were no differences in number of ECT sessions between
responders and non-responders (P= 0.93).
Additional information about the clinical characteristics of each
patient, such as age at onset, number of depressive episodes,
duration of the current episode, melancholic and psychotic features
and details about medication history is presented in Supplementary
Table 1A. Details about the ECT course of each patient are provided
in Supplementary Table 1B (number of ECT sessions, pulse width,
charge at start and end of ECT course, seizure duration at start and
end). There was a signiﬁcant difference between both charge and
seizure duration at the start and end of the ECT course (mean
charge start 175 mC; end 393 mC; Po0.001; mean seizure duration
start = 52 s; end 36; Po0.001).
Cross-sectional effects
Whole-brain comparisons for baseline cortical thickness between
MDD patients and healthy controls revealed no signiﬁcant
differences between the two groups.
Longitudinal effects of ECT
Whole-brain comparisons revealed large bilateral clusters (left
2886 mm2, right 3599mm2) of increased thickness after ECT
treatment. These clusters extended from the temporal pole, middle
and superior temporal cortex to the insula and inferior temporal
cortex in the left hemisphere (see Figure 1 and Table 2). There were
no areas showing a signiﬁcant decrease of cortical thickness in the
longitudinal analysis, neither were there changes in cortical
thickness in the healthy controls in the longitudinal analysis.
Relations between increase in cortical thickness, treatment
response and clinical variables
The whole-brain analysis did not give rise to signiﬁcant differences
in cortical thickness between responders and non-responders as a
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function of ECT treatment. In a next step, we took the mean
thickness of predeﬁned cortical parcellations, which were included
within the bilateral cluster of increased cortical thickness, and
compared responders and non-responders to ECT. Supplementary
Table 2 presents the absolute increases of the predeﬁned cortical
parcellations that were identiﬁed in the second step. Independent
t-tests of changes in thickness of both the left and the right insula
revealed signiﬁcant differences between responders and non-
responders; responders showed a larger increase in cortical
thickness than non-responders (left insula; P= 0.017, and right
insula; P= 0.017). Changes in cortical thickness of the temporal
pole and temporal cortex (inferior, middle and superior) did not
differ between responders and non-responders.
Exploratory correlational analyses with clinical variables
revealed that the change in HDRS score was negatively correlated
with change in mean cortical thickness of the right insula
Figure 1. Increases in cortical thickness in MDD patients (n= 19) during ECT treatment in comparison with healthy controls (n= 16) on inﬂated
brain. Shown is the statistical output of QDEC, the graphical interface of Freesurfer, with the results corrected for multiple comparisons by
Monte Carlo Z simulation*. (a) Left hemisphere, with a large cluster in yellow extending from temporal pole, middle and superior temporal
cortex to the insula and the inferior temporal cortex. (b) Right hemisphere, with a large cluster in yellow extending from the temporal pole to
the insula. *Monte Carlo Null-Z simulation, threshold 0.005 (absolute). MDD, major depressive disorder.
Table 1. Demographical and clinical characteristics of the MDD patients and matched healthy control
Patients (n=23) Healthy (n=22) Group difference Pa
Age (years) 50.7 (8.5) 50.8 (8.8) 0.98
Sex (male/female) 8/15 8/14 0.91b
Education (1–5)c 3.2 (0.9) 3.4 (0.8) 0.58
Handedness (right/left) 21/2 19/3 0.60b
HDRS 17 baseline 21.9 (5.3) — —
HDRS 17 after ECT 12.6 (7.1) — —
Responders (% of patients) 13 (57%) — —
Age at onset (years) 40.8 (10.9) — —
Number of depressive episodes 2.8 (1.5) — —
Duration current episode (months) 31.0 (52.7) — —
Psychotic features (present/not present) 6/17 — —
Melancholic features (present/not present) 15/8 — —
ECT sessions 16.9 (6.2) — —
Abbreviations: ECT, electroconvulsive therapy; HDRS, Hamilton Depression Rating Scale 17 item; MDD, major depressive disorder. Data are expressed as mean
(s.d.) unless otherwise speciﬁed. aIndependent t-test. bPearson's Χ2 for categorical variables. cEducational level is coded level 1–5 (5= academic), according to
the Dutch education system.
Table 2. Longitudinal changes in cortical thickness (SPC) in MDD patients during ECT treatment (n= 19) in comparison with healthy controls (n= 16)
Size (mm2) Talairach (x y z) Number of vertices Clusterwise Pa
MDD4healthy controls, left hemisphere
Temporal pole 2886 − 28 6 –34 5527 0.0001
Middle temporal cortex 791 − 58 − 56 − 2 1178 0.0001
MDD4healthy controls, right hemisphere
Insula 3599 37 −13 2 7970 0.0001
Abbreviations: ECT, electroconvulsive therapy; MDD, major depressive disorder; SPC, symmetrized percent change. aMonte Carlo null-Z simulation, threshold
0.005 (absolute).
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(r=− 0.45; P= 0.028; one-tailed). The number of ECT sessions was
positively correlated with change in mean thickness of the left
temporal pole (r= 0.43; P= 0.035 one-tailed), the left middle
temporal cortex (r= 0.51; P= 0.013 one-tailed) and the left inferior
temporal cortex (r= 0.45; P= 0.028 one-tailed). There were no
signiﬁcant correlations with age and change in seizure duration or
change in electrical charge between the ﬁrst and last ECT session.
DISCUSSION
In this study, we believe we show for the ﬁrst time that ECT
induces signiﬁcant increases in cortical thickness in treatment-
resistant MDD patients. We used bilateral ECT, which induced
large bilateral increases in cortical thickness, including the
temporal pole, the inferior and middle temporal cortex and
the insula. Post hoc analyses revealed that increased thickness of
the bilateral insular cortex differentiated responders and non-
responders to ECT, which may point to a speciﬁc relationship of
this region with treatment effects. Below we will discuss these
ﬁndings in more detail.
The widespread increases in cortical thickness that were
revealed in this study extend the existing animal and human
data on neuroplastic effects of ECT, pointing to broader
neuroplastic effects of ECT in MDD, beyond effects in the
hippocampus and amygdala that were reported before.8,11,12,30
Although neuroimaging data do not allow us to directly
investigate the exact nature of these neuroplastic effects, it can
be assumed that increases in cortical thickness could reﬂect
changes in neurons, glia cells or neuropil.31 Increased cortical
thickness was predominant in regions such as temporal cortex
that are subjected to the highest electric ﬁeld strength and may
therefore be associated with seizure onset.6,7 Previous research
has found direct effects of ECT on cerebral blood ﬂow32 and gray
matter volume voxel based morphometry9,13 in these regions and
this pattern suggests that the changes are a direct consequence of
seizure onset that is induced by ECT.
In the course of treatment, most patients show an increase in
seizure threshold and a decrease in seizure duration,33,34 pointing
to additional anticonvulsive properties of ECT that may also count
for its clinical effectiveness.33,35 Speculatively, the increased
cortical thickness could drive these anticonvulsant properties of
ECT, possibly by means of an increase in GABAergic inhibitory
interneurons or glia cells, in line with the anticonvulsant
mechanisms of ECT.33,35 Previous reports have found increases
in cortical and serum GABA levels in patients following ECT
treatment,36,37 which in turn increase the expression of neuro-
trophic factors such as brain-derived neurotrophic factor.38 Animal
models of ECT have indicated that the neuroplasticity effects of
ECT are mediated by increases in vascular endothelial growth
factor and brain-derived neurotrophic factor.39–41 Increased
GABAergic neurotransmission could also be relevant therapeuti-
cally via restoration of cortical control over hyperactive limbic
structures, through a process known as cortical inhibition.42 ECT
patients in our sample showed an increase in charge between the
ﬁrst and last ECT session and a decrease in seizure duration, which
may point to anticonvulsive properties of ECT. Additional
correlational analysis with these parameters and the changes in
cortical thickness could not establish a direct relation of increases
cortical thickness with anticonvulsant properties of ECT.
When comparing responders and non-responders to ECT, we
found a response-related effect in the bilateral insular cortex.
Though still explorative in nature, this increase could be a
response marker for therapeutic effects of ECT. These ﬁndings add
to the increasing amount of evidence implicating the insular
region as an important structure in the pathophysiology of
MDD.43–46 The insula monitors internal states,47 is involved in
emotional and sensorimotor processing and has extensive
connections with default mode network regions.48 MDD is
associated with decreased interoceptive activity and altered
activity and connectivity in the insula49 and earlier research has
found strong gray matter reductions in the insular cortex in MDD
patients.45 Several studies have identiﬁed the insula as an neural
correlate of treatment response in MDD.48 An inability to control
internal emotional states could explain core symptoms of
depression and restoration of this function would potentially
explain part of the treatment effect of ECT.
Our study is limited by the relatively small sample size, which
may account for the absence of baseline differences between
MDD patients and matched controls, and which makes it also
difﬁcult to establish differences between responders and non-
responders. While this should be a clear goal of future studies, we
would like to emphasize that patients were otherwise homo-
genous in terms of diagnosis and free of any medication that may
have interfered with potential effects of ECT. We found bilateral
changes in cortical thickness associated with the method of
bilateral stimulation, which is in line with increases in gray matter
volume in the temporal cortex that were revealed by Ota et al.13 In
contrast, right unilateral stimulation seems to induce a different
pattern of neuroplastic changes. Abbott et al.10 found that right
unilateral ECT induced a right-sided increase in hippocampal
volume and connectivity after ECT and Dukart et al.9 reported an
increase in gray matter volume in the right anterior temporal pole
and insula. At odds with these lateralization effects is the study by
Joshi et al.12 who found bilateral increases in both hippocampal
and amygdala volumes in a sample of patients who received
predominantly right unilateral ECT. Possibly, not the stimulation
method per se, but rather the capacity of electrical stimulation to
induce a generalized seizure may determine the pattern of
neuroplastic responses. Also it not clear what determines the
differences between the hemispheres that are apparent in
Figures 1a and b. Another limitation is that we do not know yet
whether these increases in cortical thickness reﬂect a temporary
effect, as was shown for the increase in volume of the
hippocampus induced by ECT50 and longer follow-up studies in
new line of ECT neuroimaging studies are certainly warranted.
In summary, we show that ECT does not only change the
neuroplasticity of subcortical brain regions, but also leads to
regional increases in cortical thickness. The localization of this
increase suggests that it is related to seizure onset in ECT.
Moreover, extension of this area of increase to the insula seems to
be an important factor, which may determine the therapeutic
response. The exact nature of these changes has to be
investigated by future research in larger samples and multimodal
imaging techniques including magnetic resonance spectroscopy.
Further it should be established whether the ECT-induced changes
in cortical thickness remain on follow-up.
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